로딩 중…
지수 로딩 중…
DAE HWA Pharmaceutical Co., Ltd.
067080· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩10,220-2.20%
2026-06-19
Price Chart
DAE HWA Pharmaceutical Co., Ltd.-33.16%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 190.26B KRW |
| Revenue | 143.42B KRW |
| Net Income | 2.48B KRW |
| Total Assets | 222.33B KRW |
| Net Assets | 85.06B KRW |
| Employees | 365 |
| Value | |
| P/E | 76.77x |
| P/B | 2.24x |
| PEG | 1.57x |
| P/S | 1.33x |
| EV/EBITDA | 114.90x |
| FCF Yield | 1.76% |
| Profitability | |
| ROE | 2.91% |
| ROA | 1.11% |
| Op. Margin | 1.73% |
| Revenue Growth | 0.99% |
| Earnings Growth | 48.91% |
| Financial Health | |
| Debt Ratio | 261.39% |
| Total Debt | 101.00B KRW |
| FCF | 3.35B KRW |
| Cash | 5.49B KRW |
| Current Ratio | 0.53x |
| Net Debt/EBITDA | 38.40x |
| Dividend | |
| Div. Yield | 1.44% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -33.16% |
| 1M Return | -20.16% |
| From 52W High | -58.96% |
| 1Y MDD | -56.14% |
| Trading | |
| Volume | 66,095 shares |
| Foreign Own. | 0.46% |
| Per Share | |
| EPS | 98 KRW |
| BPS | 4,388 KRW |
Company Info
Established in 1984 and listed on KOSDAQ in 2003, Daehwa Pharmaceutical is an innovative pharmaceutical company with 5 subsidiaries, including 3 domestic and 2 overseas. It engages in pharmaceutical manufacturing, wholesale, medical information systems, and the manufacturing and sales of pharmaceutical raw materials, cosmetics, and medical devices. The company produces treatments for infectious and digestive diseases at its GMP-certified factories, capturing 65% of the domestic OEM market. Daehwa Pharmaceutical is headquartered in Hoengseong-gun, Gangwon-do.